Moderna has gained $125 million in preferred equity for its messenger RNA (mRNA) cancer vaccine partnership with Merck, following on...
Read More...
The post Moderna/Merck cancer vaccine partnership raises $125m appeared first on Drug Development Technology.
Original Article: Moderna/Merck cancer vaccine partnership raises $125m